Emerging therapies for cystic fibrosis lung disease
Authors:
- 15 July 2010
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Emerging Drugs
- Vol. 15 (4) , 653-659
Abstract
(2010). Emerging therapies for cystic fibrosis lung disease. Expert Opinion on Emerging Drugs: Vol. 15, No. 4, pp. 653-659.Keywords
This publication has 44 references indexed in Scilit:
- Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770Proceedings of the National Academy of Sciences, 2009
- Plant host and sugar alcohol induced exopolysaccharide biosynthesis in the Burkholderia cepacia complexMicrobiology, 2008
- CFTR Function and Prospects for TherapyAnnual Review of Biochemistry, 2008
- New pulmonary therapies for cystic fibrosisCurrent Opinion in Pulmonary Medicine, 2007
- Pilot study of safety and tolerability of inhaled hypertonic saline in infants with cystic fibrosisPediatric Pulmonology, 2007
- Cell surface dynamics of CFTR: The ins and outsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2007
- In vitroprediction of stop-codon suppression by intravenous gentamicin in patients with cystic fibrosis: a pilot studyBMC Medicine, 2007
- Design, Synthesis, and Structure−Activity Relationships of Novel 2-Substituted Pyrazinoylguanidine Epithelial Sodium Channel Blockers: Drugs for Cystic Fibrosis and Chronic BronchitisJournal of Medicinal Chemistry, 2006
- Rescue of ΔF508-CFTR trafficking and gating in human cystic fibrosis airway primary cultures by small moleculesAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2006
- Cystic fibrosis: molecular biology and therapeutic implicationsScience, 1992